DG
CRL icon

Daventry Group’s Charles River Laboratories CRL Stock Holding History

Daventry Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-106,823
Closed -$21M – 10
2024
Q3 		$21M Sell
106,823
-12,872
-11% -$2.68M 8.37% 6
2024
Q2 		$24.7M Buy
119,695
+4,033
+3% +$914K 11.04% 4
2024
Q1 		$31.3M Buy
115,662
+4,500
+4% +$1.07M 12.53% 3
2023
Q4 		$26.3M Buy
111,162
+32,554
+41% +$6.4M 11.28% 5
2023
Q3 		$15.4M Buy
78,608
+6,985
+10% +$1.43M 9.82% 6
2023
Q2 		$15.1M Buy
71,623
+8,500
+13% +$1.69M 11.15% 7
2023
Q1 		$12.7M Buy
+63,123
New +$14.3M 8.91% 7

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return